PhRMA Sees Canadian Currency Devaluation As Grounds For Trade Action
Executive Summary
PhRMA believes that the inability of pharmaceutical manufacturers to raise prices in Canada to reflect the devaluation of the Canadian dollar is "contrary to the spirit" of the North American Free Trade Agreement.